AboutContactTerms & Privacy
© 2026 Coverager
All Rights Reserved

89bio

89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.

Headquarters
San Francisco, California, United States
Founded
2018
Operating Status
Acquired, Active
Ownership Type
Links
Number of funding rounds 9
Number of investors 5
Total funding amount $1.19B
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.